Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial

Abstract Background While the introduction of checkpoint inhibitors (CPIs) as standard of care treatment for various tumor types has led to considerable improvements in clinical outcome, the majority of patients still fail to respond. Preclinical data suggest that stereotactic body radiotherapy (SBR...

Full description

Bibliographic Details
Main Authors: Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer, Veerle Surmont, Annabel Meireson, Lieve Brochez, Dries Reynders, Els Goetghebeur, Robbe Van den Begin, Dirk Van Gestel, Vincent Renard, Piet Dirix, Pieter Mestdagh, Piet Ost
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Head and neck squamous cell carcinoma
Melanoma
Non-small-cell lung carcinoma
Renal cell carcinoma
Transitional cell carcinoma
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-021-08088-w

Internet

https://doi.org/10.1186/s12885-021-08088-w

Similar Items